Work

Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study

Year: 2018

Type: article

Source: Platelets

DOI: 10.1080/09537104.2018.1478404

Authors: William A. E. Parker, Niclas Eriksson, Richard C. Becker, Deepak Voora, Axel Åkerblom, Anders Himmelmann, Stefan K. James, Lars Wallentin, Robert F. Storey, on behalf of the PLATO Investigators

Institutions: University of Sheffield, Uppsala University, University of Cincinnati, Duke Medical Center, Duke Clinical Research Institute, AstraZeneca (Sweden)

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, British Heart Foundation, NIH Clinical Center, Duke Clinical Research Institute

Award: The impact of aspirin dose modification on the innate immune response

OpenAlex ID: W2805469344

FWCI: 0.756

Cites: 28

Cited by: 6

Related to: 10